About 355,000 results
Open links in new tab

  1. Explore More News

    See more news
  2. People also ask
    Who opposes Novo Holdings' $16.5 billion acquisition of Catalent?
    A coalition of unions, consumer groups, and public interest organizations has written to Lina Khan, Chair of the Federal Trade Commission (FTC), voicing strong opposition to Novo Holdings’ proposed $16.5 billion acquisition of Catalent Inc. (NYSE:CTLT).

    After US Senator, Unions Urge Federal Trade Commission To Block Nov…

    msn.com
    Will Novo Nordisk buy Catalent?
    U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, the controlling shareholder of Novo Nordisk , from acquiring contract drug manufacturer Catalent , saying the deal threatens competition in weight loss drugs and cutting-edge gene therapies.

    Consumer groups ask FTC to block Novo Holdings-Catalent deal

    reuters.com
    Does Novo Nordisk still work with FTC & EU regulators?
    "We have and will continue to work closely with the FTC and EU regulators as intended under the law. We still expect the transaction to close toward the end of the calendar year," Novo Nordisk said in its response to the consumer groups' letter.

    Consumer groups ask FTC to block Novo Holdings-Catalent deal

    reuters.com
    Will Novo's $16.5 billion deal boost supply of wegovy?
    U.S. Public Interest Research Group, Service Employees International Union (SEIU) and others expressed concerns in a letter to the FTC about the $16.5 billion deal, which Novo Holdings has said would boost supply of Wegovy, Novo's blockbuster GLP-1 injectable weight-loss drug.

    Consumer groups ask FTC to block Novo Holdings-Catalent deal

    reuters.com
    Could Novo's acquisition lead to a'vertical foreclosure'?
    The letter outlines concerns that the acquisition could lead to “vertical foreclosure,” limiting access for Novo’s current and future rivals in GLP-1 drugs and gene therapies. Catalent, with its 50 global facilities, has been an industry leader in manufacturing GLP-1 drugs, including Novo’s own Ozempic and Wegovy.

    After US Senator, Unions Urge Federal Trade Commission To Block Nov…

    msn.com
    Does Novo Nordisk still make GLP-1 products?
    Novo Nordisk has said it is committed to honoring existing contracts at the plants, and that it is not aware of any competitive GLP-1 products being manufactured for commercial sale at the three sites. "We have and will continue to work closely with the FTC and EU regulators as intended under the law.

    Consumer groups ask FTC to block Novo Holdings-Catalent deal

    reuters.com
    Feedback
  3. Reuters
    https://www.reuters.com › business › healthcare...

    Consumer groups ask FTC to block Novo Holdings-Catalent deal

    See results only from reuters.com
  4. Fierce Pharma
    https://www.fiercepharma.com › pharma

    Warren challenges Novo Holdings' proposed Catalent buyout

    Tags:
    Novo Nordisk
    Elizabeth Warren
  5. Reuters
    https://www.reuters.com › markets › deals

    Novo Nordisk's parent to buy Catalent for $16.5 bln to …

    Feb 5 (Reuters) - Novo Nordisk (NOVOb.CO) notched a win on Monday in its race to boost output of its popular obesity drug Wegovy, with its parent company announcing it was buying Catalent...

    Tags:
    Novo Nordisk
    Reuters
  6. Catalent
    https://investor.catalent.com › financial-news › news...

    Novo Holdings to Acquire Catalent

    Tags:
    Novo Nordisk
    Acquire
  7. Fierce Pharma
    https://www.fiercepharma.com › pharma

    Novo antes up $16.5B to poach CDMO giant Catalent …

    Feb 5, 2024 · Novo Holdings, which operates under Novo Nordisk’s owner the Novo Nordisk Foundation, is laying out $16.5 billion to snap up contract manufacturing giant Catalent, the companies revealed...

    Tags:
    Novo Nordisk
    Contract manufacturing organization
  8. Yahoo Finance
    https://finance.yahoo.com › news › cat…

    Catalent Stockholders Approve Transaction with Novo …

    May 29, 2024 · Based on the preliminary count of the voting results from today’s Special Meeting, Catalent stockholders voted to approve the transaction with 99.2% of ballots cast in favor of the proposed ...

  9. Reuters
    https://www.reuters.com › markets › deals › catalent...

    Catalent stockholders approve buyout by Novo Holdings

    Tags:
    Novo Nordisk
    Approval voting
  10. Catalent
    https://investor.catalent.com › financial-n…

    Catalent Stockholders Approve Transaction with Novo …

    May 29, 2024 · Catalent Stockholders Approve Transaction with Novo Holdings. May 29, 2024. SOMERSET, N.J.-- (BUSINESS WIRE)-- Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better …

  11. Financial Times
    https://www.ft.com › content

    Novo to use Ozempic and Wegovy windfall to invest …

    Feb 12, 2024 · Novo Holdings, the controlling shareholder of Danish drugmaker Novo Nordisk, plans to invest up to $7bn annually by 2030, as dividend payments from the maker of diabetes drug Ozempic and weight...

  12. MSN
    https://www.msn.com › en-us › money › companies › us...

    US Senator Warren calls for scrutiny of Novo Holdings' Catalent …